A Risk Sciences International news item posted on December 12, 2016 and last updated on August 18, 2019

Because there is limited information available concerning the use of psychiatric drugs among the US adult population, Drs Moore and Mattison sought to characterize adult use of psychiatric drugs using publicly available, nationally representative data.  These analyses demonstrate that 1 of 6 US adults reported taking psychiatric drugs at least once during 2013, but with 2- to 3-fold differences by race/ethnicity, age, and sex.

http://www.nytimes.com/2016/12/12/health/one-in-6-american-adults-say-they-have-taken-psychiatric-drugs-report-says.html

http://www.cbsnews.com/news/psychiatric-drugs-study-reveals-widespread-use-women-men/

To read the journal article, click here.

 

 

 

 

More RSI News

Roger Rempel joins RSI as Director of Climate Group

February 28, 2017

RSI is pleased to announce that Roger Rempel has joined us as the Director of the RSI Climate Group. Roger is a senior environmental engineer…

Norman Shippee joins RSI

February 28, 2017

RSI is pleased to announce that Norman Shippee recently joined the team as a Climate and Applications Specialist. Dr. Shippee earned his PhD at the…

Emma Hartnett receives Chauncey Starr Distinguished Young Risk Analyst Award

December 15, 2016

The Society for Risk Analysis (SRA) Council has awarded Dr. Hartnett the 2016 Chauncey Starr Distinguished Young Risk Analyst Award. The Chauncey Starr Distinguished Young…

RSI launches game-changing climate app

June 30, 2016

RSI launched the Climate Change Hazards Information Portal (CCHIP).